Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
10/11/2006 | EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
10/11/2006 | EP1708811A1 Catalyst for synthesis of 2-and 4-picolines, process for preparing 2- and 4-picoline and process for preparing the catalyst |
10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
10/11/2006 | CN1845980A 电致发光装置 Electroluminescent devices |
10/11/2006 | CN1845921A Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPP-IV inhibitors |
10/11/2006 | CN1845915A Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
10/11/2006 | CN1845673A Pyridinylanilides |
10/11/2006 | CN1844100A Process for preparing Torasemide intermediate and its analogue |
10/10/2006 | US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
10/10/2006 | US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes |
10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
10/10/2006 | US7119122 Compounds for the inhibition of nitric oxide synthase |
10/10/2006 | US7119110 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
10/10/2006 | US7119109 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
10/10/2006 | US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer |
10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
10/05/2006 | WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors |
10/05/2006 | WO2006105076A2 Processes for preparing monomer complexes |
10/05/2006 | WO2006105023A1 Pyridine derivatives useful as inhibitors of pkc-theta |
10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
10/05/2006 | WO2006103503A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
10/05/2006 | WO2006103463A1 Iron modulators |
10/05/2006 | WO2006103342A2 Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same |
10/05/2006 | WO2006091800A3 Novel pyridine derivatives as potassium ion channel openers |
10/05/2006 | WO2006091796A3 Compositions and methods for diagnosing and treating retinal diseases |
10/05/2006 | WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
10/05/2006 | WO2006077387A3 Novel benzamide derivatives |
10/05/2006 | WO2006011050A3 Pyridine derivatives |
10/05/2006 | WO2005116198A3 Methods of 1,3-enyne preparation using copper (i) catalysts |
10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
10/05/2006 | US20060223995 Superhigh purity ionic liquid |
10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
10/05/2006 | US20060222584 Salts comprising cyanoborate anions |
10/05/2006 | US20060220004 with Tris(2-bromo-6-pyridyl)phosphine oxide ligands; organic light-emitting diodes, integrated circuits, organic field-effect transistors, thin-film transistors, organic solar cells, and/or laser diodes |
10/05/2006 | DE102005014822A1 Verfahren zur Herstellung aromatischer Aldehyde A process for preparing aromatic aldehydes |
10/05/2006 | CA2602566A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
10/05/2006 | CA2602250A1 Pyridine derivatives useful as inhibitors of pkc-theta |
10/04/2006 | EP1707564A2 Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
10/04/2006 | EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative |
10/04/2006 | EP1707548A1 Method of deuteration using mixed catalyst |
10/04/2006 | EP1706402A1 Cathepsin cysteine protease inhibitors |
10/04/2006 | EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia |
10/04/2006 | EP1706382A1 Method for stabilizing 4-halogenpyridines with secondary and/or tertiary amines |
10/04/2006 | EP1706381A2 Process for the manufacture of 2,3-dichloropyridine |
10/04/2006 | EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
10/04/2006 | EP1543014B1 Preparation of metal complexes |
10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
10/04/2006 | EP0906091B1 Amidinohydrazones as protease inhibitors |
10/04/2006 | CN1842272A Hydrazone derivatives for combatting harmful insects and arachnids |
10/04/2006 | CN1277824C Piperazine derivatives |
10/04/2006 | CN1277545C Use of bisphosphonates in preparing medicine for the treatment of bone metastasis associated with prostate cancer |
10/04/2006 | CN1277528C Dyeing composition for kerationous fibres comprising particular dicationic diazo dye |
10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
10/03/2006 | US7115769 Catalyzing the alkylation, forming a 2-alkylcysteine derivatives, a chemical intermediates for iron chelating agents |
10/03/2006 | US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives |
10/03/2006 | US7115752 Substituted cyclic compounds |
10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
10/03/2006 | US7115746 Processes for the facile synthesis of diaryl amines and analogues thereof |
10/03/2006 | US7115666 Analgesics; trauma brain injuries ; antiarthritic agents |
10/03/2006 | US7115664 Peptidomimetic ligands for cellular receptors and ion channels |
10/03/2006 | US7115654 Caspase-1 inhibitors and methods for their use |
10/03/2006 | US7115652 Aspartyl protease inhibitors |
10/03/2006 | US7115637 Inhibitors of p38 |
10/03/2006 | US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants |
10/03/2006 | US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
10/03/2006 | US7115611 Phenyl derivatives, their manufacture and use as pharmaceutical agents |
10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
10/03/2006 | US7115605 Peptide deformylase inhibitors |
10/03/2006 | US7115600 Histamine-3 receptor modulators |
10/03/2006 | US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
10/03/2006 | CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
09/28/2006 | WO2006102645A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
09/28/2006 | WO2006101144A1 Charge control agent and related technique |
09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
09/28/2006 | WO2006100039A1 Carboxanilides as microbiocides |
09/28/2006 | WO2006099968A1 Metabolites for nk-i antagonists for emesis |
09/28/2006 | WO2006099684A1 Copper complexes |
09/28/2006 | WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
09/28/2006 | WO2006060731A3 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
09/28/2006 | WO2006044975A3 Compositions and their use as anti-tumor agents |
09/28/2006 | WO2006025979A3 Modulators of nuclear receptors |
09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
09/28/2006 | US20060217561 Synthesis of substituted thiazoline carboxylic acids |
09/28/2006 | US20060217558 Method for producing 1, 3-dialkylpyridinium oligomers and related compounds using a solid support |
09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
09/28/2006 | US20060217426 Compound inhibiting in vivo phosphorous transport and medicine containing the same |
09/28/2006 | US20060217424 Compounds for the inhibition of nitric oxide synthase |
09/28/2006 | US20060217412 Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
09/28/2006 | US20060217403 Substituted 2-aminoacetamides and the use thereof |
09/28/2006 | US20060217398 Substituted pyrimidine derivatives |
09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
09/28/2006 | US20060217349 Having antiinflammatory, anti-pyretic and anti-diarrheal properties |